AFT Forsyth & Company’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Sell |
3,865
-25
| -0.6% | -$8.91K | 0.64% | 38 |
|
|
2025
Q4 | $1.27M | Hold |
3,890
| – | – | 0.55% | 45 |
|
|
2025
Q3 | $1.1M | Sell |
3,890
-25
| -0.6% | -$7.25K | 0.53% | 42 |
|
|
2025
Q2 | $1.09M | Sell |
3,915
-100
| -2% | -$28.3K | 0.56% | 40 |
|
|
2025
Q1 | $1.25M | Sell |
4,015
-155
| -4% | -$45.8K | 0.67% | 37 |
|
|
2024
Q4 | $1.09M | Sell |
4,170
-65
| -2% | -$19.3K | 0.53% | 42 |
|
|
2024
Q3 | $1.36M | Buy |
4,235
+300
| +8% | +$98.1K | 0.67% | 34 |
|
|
2024
Q2 | $1.23M | Buy |
3,935
+345
| +10% | +$101K | 0.6% | 38 |
|
|
2024
Q1 | $1.02M | Sell |
3,590
-269
| -7% | -$78.7K | 0.58% | 43 |
|
|
2023
Q4 | $1.11M | Buy |
3,859
+25
| +0.7% | +$6.81K | 0.7% | 39 |
|
|
2023
Q3 | $1.03M | Buy |
3,834
+251
| +7% | +$62.6K | 0.76% | 38 |
|
|
2023
Q2 | $796K | Sell |
3,583
-212
| -6% | -$49.2K | 0.56% | 51 |
|
|
2023
Q1 | $917K | Sell |
3,795
-74
| -2% | -$18.2K | 0.71% | 43 |
|
|
2022
Q4 | $1.02M | Sell |
3,869
-23
| -0.6% | -$6.17K | 0.87% | 35 |
|
|
2022
Q3 | $877K | Buy |
3,892
+6
| +0.2% | +$1.45K | 0.78% | 38 |
|
|
2022
Q2 | $946K | Buy |
3,886
+15
| +0.4% | +$3.68K | 0.76% | 37 |
|
|
2022
Q1 | $936K | Sell |
3,871
-137
| -3% | -$31.5K | 0.6% | 47 |
|
|
2021
Q4 | $902K | Sell |
4,008
-314
| -7% | -$66.3K | 0.46% | 66 |
|
|
2021
Q3 | $919K | Sell |
4,322
-150
| -3% | -$34.5K | 0.49% | 63 |
|
|
2021
Q2 | $1.09M | Sell |
4,472
-19
| -0.4% | -$4.67K | 0.58% | 53 |
|
|
2021
Q1 | $1.12M | Hold |
4,491
| – | – | 0.67% | 44 |
|
|
2020
Q4 | $1.03M | Buy |
4,491
+175
| +4% | +$40.3K | 0.65% | 46 |
|
|
2020
Q3 | $1.1M | Sell |
4,316
-149
| -3% | -$36.9K | 0.82% | 34 |
|
|
2020
Q2 | $1.05M | Buy |
4,465
+45
| +1% | +$10.3K | 0.89% | 34 |
|
|
2020
Q1 | $896K | Sell |
4,420
-815
| -16% | -$178K | 0.9% | 33 |
|
|
2019
Q4 | $1.26M | Buy |
5,235
+100
| +2% | +$22K | 0.96% | 29 |
|
|
2019
Q3 | $994K | Buy |
5,135
+200
| +4% | +$38.4K | 0.82% | 43 |
|
|
2019
Q2 | $909K | Sell |
4,935
-30
| -0.6% | -$5.37K | 0.75% | 46 |
|
|
2019
Q1 | $943K | Buy |
4,965
+125
| +3% | +$23.9K | 0.82% | 43 |
|
|
2018
Q4 | $942K | Hold |
4,840
| – | – | 0.94% | 34 |
|
|
2018
Q3 | $1M | Buy |
4,840
+391
| +9% | +$77.1K | 0.83% | 43 |
|
|
2018
Q2 | $821K | Buy |
4,449
+210
| +5% | +$37.1K | 0.72% | 49 |
|
|
2018
Q1 | $723K | Buy |
4,239
+105
| +3% | +$19.3K | 0.67% | 51 |
|
|
2017
Q4 | $719K | Buy |
+4,134
| New | +$732K | 0.7% | 45 |
|
|
2013
Q3 | $342K | Buy |
3,059
+330
| +12% | +$35.8K | 0.44% | 76 |
|
|
2013
Q2 | $269K | Buy |
+2,729
| New | +$283K | 0.38% | 77 |
|
Other funds holding AMGN
VCM
VPM
AFT Forsyth & Company's AMGN Position: Q1 2026 in Review
AFT Forsyth & Company reduced its Amgen (AMGN) stake by 0.64% in Q1 2026, selling an estimated $8.91K and leaving 3,865 shares worth $1.36M. The position accounts for 0.64% of the portfolio, ranked #38.
AFT Forsyth & Company first reported a position in AMGN in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.36M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- AFT Forsyth & Company held 3,865 shares of Amgen worth $1.36M as of Q1 2026.
- AFT Forsyth & Company sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
- Amgen made up 0.64% of AFT Forsyth & Company's portfolio in Q1 2026, its #38 holding.
- AFT Forsyth & Company first reported a position in Amgen in Q2 2013 and has held it in 36 quarters since.
- AFT Forsyth & Company's Amgen position peaked at $1.36M in Q3 2024.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on AFT Forsyth & Company's 13F filing for Q1 2026, filed 14 May 2026.